Biovail, J&J Unit Hit Par With Third Ultram Suit

By Ben James (October 25, 2007, 12:00 AM EDT) -- A group of plaintiffs including Purdue Pharma Products LP and Johnson & Johnson subsidiary Ortho-McNeil Inc. has filed a patent suit against Par Pharmaceuticals in a bid to protect the market for the chronic pain treatment Ultram, marking at least the third suit the plaintiffs have filed against Par over Ultram since May....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!